» Articles » PMID: 39872985

CIDEC/FSP27 Exacerbates Obesity-related Abdominal Aortic Aneurysm by Promoting Perivascular Adipose Tissue Inflammation

Overview
Journal Life Metab
Date 2025 Jan 28
PMID 39872985
Authors
Affiliations
Soon will be listed here.
Abstract

Abdominal aortic aneurysm (AAA) is strongly correlated with obesity, partially due to the abnormal expansion of abdominal perivascular adipose tissue (PVAT). Cell death-inducing DNA fragmentation factor-like effector C (CIDEC), also known as fat-specific protein 27 (FSP27) in rodents, is specifically expressed in adipose tissue where it mediates lipid droplet fusion and adipose tissue expansion. Whether and how CIDEC/FSP27 plays a role in AAA pathology remains elusive. Here, we show that FSP27 exacerbates obesity and angiotensin Ⅱ (Ang Ⅱ)-induced AAA progression. FSP27 deficiency in mice inhibited high-fat diet-induced PVAT expansion and inflammation. Both global and adipose tissue-specific FSP27 ablation significantly decreased obesity-related AAA incidence. Deficiency of FSP27 in adipocytes abrogated matrix metalloproteinase-12 (MMP12) expression in aortic tissues. Infiltrated macrophages, which partially colocalize with MMP12, were significantly decreased in the FSP27-deficient aorta. Mechanistically, knockdown of in 3T3-L1 adipocytes inhibited C-C motif chemokine ligand 2 (CCL2) expression and secretion through a c-Jun N-terminal kinase (JNK)-dependent pathway, thereby leading to reduced induction of macrophage migration, while overexpression rescued this effect. Overall, our study demonstrates that CIDEC/FSP27 in adipose tissue contributes to obesity-related AAA formation, at least in part, by enhancing PVAT inflammation and macrophage infiltration, thus shedding light on its significance as a key regulator in the context of obesity-related AAA.

Citing Articles

SNORD80-guided 2'-O-methylation stabilizes the lncRNA GAS5 to regulate cellular stress responses.

Xu L, Zhao X, Zhang Y, Zhang M, Zhang L, Ye K Proc Natl Acad Sci U S A. 2025; 122(7):e2418996122.

PMID: 39946530 PMC: 11848286. DOI: 10.1073/pnas.2418996122.

References
1.
Davis F, Rateri D, Daugherty A . Abdominal aortic aneurysm: novel mechanisms and therapies. Curr Opin Cardiol. 2015; 30(6):566-73. PMC: 4624089. DOI: 10.1097/HCO.0000000000000216. View

2.
Curci J, Liao S, Huffman M, Shapiro S, Thompson R . Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest. 1998; 102(11):1900-10. PMC: 509141. DOI: 10.1172/JCI2182. View

3.
Cronin O, Walker P, Golledge J . The association of obesity with abdominal aortic aneurysm presence and growth. Atherosclerosis. 2012; 226(2):321-7. DOI: 10.1016/j.atherosclerosis.2012.10.041. View

4.
Russo S, Kwiatkowski M, Govorukhina N, Bischoff R, Melgert B . Meta-Inflammation and Metabolic Reprogramming of Macrophages in Diabetes and Obesity: The Importance of Metabolites. Front Immunol. 2021; 12:746151. PMC: 8602812. DOI: 10.3389/fimmu.2021.746151. View

5.
Nishimoto Y, Nakajima S, Tateya S, Saito M, Ogawa W, Tamori Y . Cell death-inducing DNA fragmentation factor A-like effector A and fat-specific protein 27β coordinately control lipid droplet size in brown adipocytes. J Biol Chem. 2017; 292(26):10824-10834. PMC: 5491769. DOI: 10.1074/jbc.M116.768820. View